Skip to main content
Clinical Trials/NCT02430519
NCT02430519
Completed
Not Applicable

Effect of Autologous Platelet Rich Fibrin In Human Mandibular Molar Grade II Furcation Defects- A Clinical and Radiological Study

Dr.Syed Asimuddin0 sites22 target enrollmentSeptember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Periodontitis
Sponsor
Dr.Syed Asimuddin
Enrollment
22
Primary Endpoint
Vertical clinical attacment level
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Background: Furcation is the bifurcation or trifurcation of a multirooted tooth. It is an area of complex anatomic morphology difficult to debride by routine periodontal instrumentation. Multiple approaches have been used in an effort to treat the furcation Choukroun's platelet-rich fibrin (PRF), a second generation platelet concentrate has biochemical components which have well known synergetic effects on healing processes. The present study was conducted to evaluate the effectiveness of autologous platelet-rich fibrin (PRF) in the treatment of mandibular molar Grade 2 furcation defects in comparison to allograft and guided tissue regeneration (GTR) membrane.

Detailed Description

ABSTRACT Background: Furcation is the bifurcation or trifurcation of a multirooted tooth. It is an area of complex anatomic morphology difficult to debride by routine periodontal instrumentation. Multiple approaches have been used in an effort to treat the furcation Choukroun's platelet-rich fibrin (PRF), a second generation platelet concentrate has biochemical components which have well known synergetic effects on healing processes. The present study was conducted to evaluate the effectiveness of autologous platelet-rich fibrin (PRF) in the treatment of mandibular molar Grade 2 furcation defects in comparison to allograft and guided tissue regeneration (GTR) membrane. MATERIALS AND METHODS: The study was designed as a randomized, prospective, parallel-arm, interventional clinical trial wherein 30 patients with periodontitis and grade II Mandibular furcation defects attending the Out Patient wing of the Department of Periodontics of a tertiary referral care hospital were equally divided into group A and group B. Patients in.Group A, were treated by the placement of PRF as a Graft and as a membrane at the surgical site , while in Group B, the defects were treated by the placement of Allograft and Healiguide collagen membrane. Plaque Index, Probing depth, Vertical clinical attachment level, Horizontal clinical attachment level, Gingival marginal level, and amount of bonefill using Radiovisiography were recorded at baseline and 9 months. Intra-group comparison of Mean scores between Group A and Group B was done using Paired t test and Inter-group comparison using independent sample t test. CONCLUSION Further studies evaluating the efficacy of PRF using a larger sample size should be performed to evaluate its true beneficial effects on long term basis in patients with mandibular molar Grade 2 furcation defects.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
May 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dr.Syed Asimuddin
Responsible Party
Sponsor Investigator
Principal Investigator

Dr.Syed Asimuddin

Post Graduate

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre

Eligibility Criteria

Inclusion Criteria

  • One or more sites showing grade II furcation involvement in mandibular molars, with Probing pocket depth ≥ 5mm
  • Vertical attachment level and horizontal level ≥3mm were considered.
  • Patients who were systemically healthy, with no history of endodontic and periodontal treatment for the last 6 months, and no antibiotic usage for the last 6 months were included in the study. Care was taken to ascertain that the samples taken for the study were not allergic to any drugs nor to the graft materials used.

Exclusion Criteria

  • Patients with a history of diabetes, hypertension, on anticoagulant or steroid therapy (which could alter the effects of PRF), cardiac diseases, insufficient platelet counts and immunocompromised individuals were excluded from the study.
  • Care was taken to exclude pregnant women and lactating mothers, smokers, patients with previous history of graft placement in the experimental site, and importantly those patients who were unable to maintain good oral hygiene (PI Score ≥ 1.5).
  • If Grade II mobility was observed after phase I therapy in the experimental teeth, they were excluded

Outcomes

Primary Outcomes

Vertical clinical attacment level

Time Frame: 9 months Post treatment

The Vertical clinical attachment level was assessed preoperatively and 9 months after surgery

Horizontal clinical attachment level

Time Frame: 9 months Post treatment

The horizontal clinical attachment level was assessed preoperatively and 9 months after surgery.

Bone fill

Time Frame: 9 months Post treatment

Bone fill was assessed radiographically and 9 months after surgery

Secondary Outcomes

  • Plaque Index(9 Months Post treatment)
  • Probing depth(9 Months Post treatment)
  • Gingival marginal level(9 months post treatment)

Similar Trials